HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

R Jorquera Selected Research

B 581

8/2001Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


R Jorquera Research Topics

Disease

1Liver Neoplasms (Liver Cancer)
08/2001
1Metabolic Diseases (Metabolic Disease)
08/2001
1Chromosomal Instability (Chromosome Stability)
08/2001
1Genomic Instability
08/2001
1Tyrosinemias (Tyrosinemia)
08/2001

Drug/Important Bio-Agent (IBA)

1PD 98059IBA
08/2001
1Glutathione (Reduced Glutathione)IBA
08/2001
1fumarylacetoacetateIBA
08/2001
1fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA
08/2001
1B 581IBA
08/2001